Medical News

RSS

Arrowhead increases ownership in Calando Pharmaceuticals through Series A Preferred Stock exchange

Arrowhead Research Corporation today announced that it has increased its ownership of majority owned subsidiary Calando Pharmaceuticals through the exchange of Calando Series A Preferred Stock for Arrowhead warrants.

23 Sep 2010

Administrator Shah praises President Obama's ground-breaking policy on global development

"From President John F. Kennedy to President Barack Obama, the United States has a rich history of providing assistance that improves the lives of men, women and children around the globe. Today President Obama issued the first-ever development policy by a U.S. President. In partnership with the host countries where we work, USAID is pleased to play a leading role in the implementation of President Obama's vision for global development.

23 Sep 2010

Aradigm Corporation receives $891,000 to purchase common stock shares

Aradigm Corporation today announced that it has received proceeds of approximately $891,000 from the exercise of all of the warrants to purchase an aggregate of 7,527,214 shares of the Company's common stock that were issued in the private placement that closed on June 21, 2010.

23 Sep 2010

GSMA recognises mobile health in 16th Annual Global Mobile Awards programme

The GSMA, which represents the interests of the worldwide mobile communications industry, has launched its prestigious 16th Annual Global Mobile Awards programme. New categories have been added to recognise excellence, achievement and innovation in the broad and constantly evolving mobile ecosystem. Specifically, the GSMA will shine a spotlight on innovation in the mobile health – 'mHealth' – space for the first time.

23 Sep 2010

Vision-Sciences, Stryker sign urology supply agreement

Vision-Sciences, Inc. announced today that it has signed a three year agreement under which Vision-Sciences will become the exclusive supplier to Stryker Corporation, through its Endoscopy division, of Stryker-branded flexible video and fiber cystoscopes.

From Stryker 23 Sep 2010

SAHA selects TeleTracking's RadarFind as exclusive real-time locating provider

The Southern Atlantic Healthcare Alliance (SAHA) has selected TeleTracking's RadarFind as the exclusive real-time locating provider for member hospitals. SAHA, which is comprised of 16 hospitals in North Carolina, chose RadarFind's real-time location system (RTLS) to enable their members to track medical equipment, patients and staff.

23 Sep 2010

InspireMD to launch MGuard Prime MicroNet stent system at TCT Conference

InspireMD, developers of the novel MGuard(TM) coronary MicroNet stent system, will introduce MGuard Prime at its booth #2052 at the TCT Conference in Washington DC, September 23-25, 2010. MGuard Prime presents an advanced Co-Cr Design of 80 micron struts along with InspireMD's unique MicroNet(R) Mesh Technology.

23 Sep 2010

CytomX Therapeutics completes $30 million Series B financing

CytomX Therapeutics, a biotechnology company focused on the development of proteolytically-activated antibodies, today announced it has completed a $30 million Series B financing.

23 Sep 2010

Covidien declares 11% increase in quarterly dividend rate

Covidien plc today announced that its Board of Directors has declared an 11% increase in the quarterly dividend rate, from $0.18 per ordinary share to $0.20 per ordinary share.

23 Sep 2010

Tolerx presents otelixizumab preclinical research at 46th EASD

Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the presentation of preclinical research describing the mechanism of action of otelixizumab at the 46th Annual Meeting of the European Association for the Study of Diabetes (EASD). In addition, Tolerx also announced that the first European patient was enrolled in DEFEND-2, a confirmatory Phase 3 clinical trial evaluating otelixizumab in autoimmune new-onset type 1 diabetes.

23 Sep 2010

BioCision launches CryoPrep System for cell freezing procedures

BioCision LLC, the CoolPrep company, announced today that it has expanded its line of innovative benchtop sample handling tools with the launch of the CryoPrep System, a modular complete solution for cell freezing procedures.

23 Sep 2010

PharmacoEconomics releases special issue on CER

Wolters Kluwer Pharma Solutions, a leading provider of scientific information and analytics to the pharmaceutical and biotech fields, announced today that the Adis journal PharmacoEconomics has released a special issue devoted entirely to comparative effectiveness research (CER).

23 Sep 2010

FDA grants ZIOPHARM's darinaparsin Orphan Drug Designation for peripheral T-cell Lymphoma treatment

ZIOPHARM Oncology, Inc. announced today that the United States Food & Drug Administration (FDA) has granted Orphan Drug Designation to darinaparsin (Zinapar™ or ZIO-101) for the treatment of peripheral T-cell Lymphoma (PTCL). The United States Orphan Drug Act of 1983 was created to provide incentives for companies to develop and market treatments for diseases or conditions affecting fewer than 200,000 people in the United States.

23 Sep 2010

Teleflex launches Gibeck Humid-Flo Passive Humidification Kit for Ventilator Associated Pneumonia risk reduction

Teleflex has introduced the Gibeck Humid-Flo Passive Humidification Kit, an integrated system that promotes best practices for Ventilator Associated Pneumonia (VAP) risk reduction. This convenient kit includes everything required to initiate passive humidification for the first 72 hours of mechanical ventilation.

23 Sep 2010

Rite Aid second quarter revenue decreases to 2.5%

Rite Aid Corporation today reported financial results for its fiscal second quarter ended August 28, 2010.

23 Sep 2010

Well designed and executed care management program cuts costs: Study

A study published today in the New England Journal of Medicine shows that a carefully designed and executed care management program cuts costs.

23 Sep 2010

ENTrigue partners with HemCon to distribute hemostatic surgical gel

HemCon Medical Technologies, a global innovative developer of advanced medical technologies and products, has recently partnered with ENTrigue Surgical, Inc., a leading provider of medical devices and therapies for surgeries of the Ear, Nose and Throat, to develop and distribute HemCon's latest breakthrough product, a hemostatic surgical gel.

23 Sep 2010

First Edition: September 23, 2010

A flurry of news coverage today highlights the health law's six-month anniversary and the specific provisions that take effect today, as well as the GOP's scheduled release of their "Pledge To America," which includes a repeal of the health overhaul among its priorities.

23 Sep 2010

New Canadian book helps demystify the health care system

If your usual cure for what ails you is to "take two pills and call in the morning" you might be in need of some better medical advice. Take as Directed is a new book from Dalhousie University pharmacy professor Neil MacKinnon and Dal Medical School alumni Rhonda Church. Aimed at helping Canadians from all walks of life navigate the health care system, Take as Directed is essential reading for anybody who is concerned about their health and well being.

23 Sep 2010

Linagliptin clinical trial data shows positive result for type 2 diabetes treatment

New data from the linagliptin late stage clinical trial programme were presented this week at the 46th Annual Meeting of the European Association for the Study of Diabetes (EASD).

23 Sep 2010